Page 24 - 南京医科大学自然版

第45卷第7期
·922 · 南 京 医 科 大 学 学 报 2025年7月

rus armed chemokine rantes for treatment of breast hanced viro ⁃ immunotherapy［J］. Neuro Oncol，2024，26
cancer［J］. Bioengineering（Basel），2022，9（8）：342 （9）：1602-1616
［56］LI S Z，LI Z X，LI Y Q，et al. A comparative study of the ［68］NABI R，MUSARRAT F，LIMA J C M P，et al. The Onco⁃
ability of recombinant oncolytic adenovirus，doxorubicin lytic herpes simplex virus type⁃1（HSV⁃1）vaccine strain
and tamoxifen to inhibit the proliferation of breast cancer VC2 causes intratumor infiltration of functionally active T
cells［J］. J Cell Mol Med，2022，26（20）：5222-5234 cells and inhibition of tumor metastasis and pro ⁃ tumor
［57］DONG J，KONG L K，WANG S Q，et al. Oncolytic adeno⁃ genes VEGF and PDL1 expression in the 4T1/Balb/c
virus encoding apolipoprotein A1 suppresses metastasis mouse model of stage four breast cancer［J］. Front Mol
of triple ⁃ negative breast cancer in mice［J］. J Exp Clin Biosci，2023，10：1199068
Cancer Res，2024，43（1）：102 ［69］VANNINI A，PARENTI F，FORGHIERI C，et al. Innova⁃
［58］XU W D，YANG Y F，HU Z B，et al. LyP⁃1⁃modified on⁃ tive retargeted oncolytic herpesvirus against nectin4⁃posi⁃
colytic adenoviruses targeting transforming growth factor tive cancers［J］. Front Mol Biosci，2023，10：1149973
β inhibit tumor growth and metastases and augment im⁃ ［70］CLARK C M，JAMBUNATHAN N，COLLANTES T M A，
mune checkpoint inhibitor therapy in breast cancer et al. Inactivation of the UL37 deamidase enhances virus
mouse models［J］. Hum Gene Ther，2020，31（15/16）： replication and spread of the HSV⁃1（VC2）oncolytic vac⁃
863-880 cine strain and secretion of GM⁃CSF［J］. Viruses，2023，
［59］AHMED J，CHARD L S，YUAN M，et al. A new oncolytic 15（2）：367
vacciniavirus augments antitumor immune responses to ［71］HALL B L，LERONNI D，MIYAGAWA Y，et al. Genera⁃
prevent tumor recurrence and metastasis after surgery［J］. tion of an oncolytic herpes simplex viral vector completely
J Immunother Cancer，2020，8（1）：e000415 retargeted to the GDNF receptor GFRα1 for specific infec⁃
［60］KIM H S，YOUN Y H，KIM H J，et al. Enhanced antitu⁃ tion of breast cancer cells［J］. Int J Mol Sci，2020，21
mor efficacy of oncolytic vaccinia virus therapy through （22）：8815
keratin⁃mediated delivery in triple⁃negative breast can⁃ ［72］BALACHANDRAN S，BARBER G N. Vesicular stomati⁃
cer［J］. Int J Mol Sci，2024，25（21）：11470 tis virus（VSV）therapy of tumors［J］. IUBMB Life，2000，
［61］ZHOU Y R，WANG Q P，YING Q，et al. A comparative 50（2）：135-138
study of oncolytic vaccinia viruses harboring different ma⁃ ［73］ASKARI F S，MOHEBBI A，MORADI A，et al. The role
rine lectins in breast cancer cells［J］. Mar Drugs，2023，21 of vesicular stomatitis virus matrix protein in autophagy
（2）：77 in the breast cancer［J］. Asian Pac J Cancer Prev，2021，
［62］CHAURASIYA S，YANG A N，KANG S，et al. Oncolytic 22（1）：249-255
poxvirus CF33⁃hNIS⁃ΔF14.5 favorably modulates tumor ［74］MCDONALD C J，ERLICHMAN C，INGLE J N，et al. A
immune microenvironment and works synergistically with measles virus vaccine strain derivative as a novel oncolytic
anti ⁃ PD ⁃ L1 antibody in a triple ⁃ negative breast cancer agent against breast cancer［J］. Breast Cancer Res Treat，
model［J］. Oncoimmunology，2020，9（1）：1729300 2006，99（2）：177-184
［63］JIA X Y，ZHAO Y J，LI Q，et al. Targeted inhibition of ［75］YANG B，SHI J W，SUN Z，et al. Attenuated measles vi⁃
p21 promotes the growth of breast cancer cells and im⁃ rus overcomes radio ⁃ and chemoresistance in human
pairs the tumor⁃killing effect of the vaccinia virus［J］. J breast cancer cells by inhibiting the non⁃homologous end
Breast Cancer，2024，27（5）：293-304 joining pathway［J］. Oncol Rep，2020，44（5）：2253-2264
［64］DENG Y，LIN Y Q，CHEN S Y，et al. Neuronal miR⁃9 pro⁃ ［76］ZHENG X Y，LV Y，XU L Y，et al. A novel approach for
motes HSV⁃1 epigenetic silencing and latency by repress⁃ breast cancer treatment：the multifaceted antitumor ef⁃
ing Oct ⁃ 1 and Onecut family genes［J］. Nat Commun， fects of rMeV⁃Hu191［J］. Hereditas，2024，161（1）：36
2024，15（1）：1991 ［77］ABDULLAH S A，AL⁃SHAMMARI A M，LATEEF S A.
［65］ALANDIJANY T. Host intrinsic and innate intracellular Attenuated measles vaccine strain have potent oncolytic
immunity during herpes simplex virus type 1（HSV⁃1）in⁃ activity against Iraqi patient derived breast cancer cell
fection［J］. Front Microbiol，2019，10：2611 line［J］. Saudi J Biol Sci，2020，27（3）：865-872
［66］SHEN Y，NEMUNAITIS J. Herpes simplex virus 1（HSV⁃1） ［78］LIU C H，WONG S H，TAI C J，et al. Ursolic acid and its
for cancer treatment［J］. Cancer Gene Ther，2006，13 nanoparticles are potentiators of oncolytic measles viro⁃
（11）：975-992 therapy against breast cancer cells［J］. Cancers（Basel），
［67］NOH M H，KANG J M，MILLER A A，et al. Targeting 2021，13（1）：136
IGF2 to reprogram the tumor microenvironment for en⁃ ［79］ALABSI A M，ALI R，IDERIS A，et al. Anti⁃leukemic ac⁃